Jacob Van Naarden - 13 Aug 2025 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres., Lilly Oncology
Signature
/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
Issuer symbol
LLY
Transactions as of
13 Aug 2025
Transactions value $
$647,360
Form type
4
Filing time
13 Aug 2025, 16:15:45 UTC
Previous filing
12 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Van Naarden Jacob EVP & Pres., Lilly Oncology LILLY CORPORATE CENTER, INDIANAPOLIS /s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file 13 Aug 2025 0001661254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Purchase $647K +1K +5.11% $647.36 20.6K 13 Aug 2025 Direct
holding LLY Common Stock 4.34K 13 Aug 2025 Van Naarden Family Trust F1
holding LLY Common Stock 4.3K 13 Aug 2025 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.